David Stein will present at the 2017 Annual Consumer Class Action Conference hosted by Bridgeport Continuing Education on January 13, 2017. He is one of two faculty members who will lead the discussion entitled “Hot Topics and Trends in Prosecuting & Defending of Consumer Class Actions.” David will provide the plaintiffs’ perspective on a number of “hot topics,” including class action waivers in arbitration agreements, personal jurisdiction in light of last year’s BMS decision, recalls and voluntary market actions, scrutiny of class settlements and an overview of some recent, significant Ninth Circuit decisions.
David Berger and Aaron Blumenthal presented at the Berkeley Center for Law and Technology on January 10, 2017 in an interactive program, entitled “Winning Strategies in Privacy and Data Security Class Actions: The Plaintiffs’ Perspective.” The discussion touched on a variety of current issues impacting complex data breach and privacy litigation, including:
On December 28, 2016, Karen Barth Menzies was appointed by United States District Judge Engelhardt, of the Eastern District of Louisiana, as Co-Lead Counsel in the In re: Taxotere (Docetaxel) Products Liability Litigation.
On December 27, 2016, Girard Gibbs LLP was selected as interim-lead counsel in litigation alleging that manufacturers of topical steroids had conspired to fix drug prices. A total of six drug makers who produce generic versions of clobetasol, desonide, and fluocinonide have been suspected of involvement. Judge William Pauley of the Southern District of New York appointed Girard Gibbs for its experience with other litigation involving the anticompetitive practices of pharmaceutical companies. To read more, click here.
Lawsuits Allege that Patients Suffered Permanent, Disfiguring Hair Loss from Chemotherapy Drug
On November 23, 2016, Eric Gibbs was appointed by Judge Holden of the District of Arizona to the Plantiffs’ Executive Committee in a lawsuit involving a massive data breach at Banner Health. Banner Health announced in August 2016 that a significant data breach may have exposed the personal health and other sensitive information of up to 3.7 million individuals (including patients, health plan members, providers and food/ beverage customers); it was one of the largest data breaches of 2016 based on number of individuals impacted.
On January 20, 2017, Daniel Girard will present at the Advanced Data Privacy, Cybersecurity and TCPA Class Action Litigation Strategies and Defenses seminar hosted by the Practising Law Institute (PLI) in San Francisco. The seminar will review recent developments on the subject and provide insight on procedural traps, preventative measures, and defense strategies. Mr. Girard will be discussing trends and sharing tips as they relate to arbitration, class action settlements, and successful provisions in recent cases. He will be joined by fellow faculty member Robert J. Herrington of Greenberg Traurig LLP.
Eric Gibbs was selected by Law360 today as a Consumer Protection MVP for 2016, the only plaintiff-side lawyer honored in this category. The Law360 MVP awards highlight leading lawyers who “have distinguished themselves from their peers by securing hard-earned successes in high-stakes litigation, complex global matters and record-breaking deals.”
Andre Mura will present today at the Harris Martin California Mass Tort and Class Action Litigation Conference analyzing the impact of Daimler and BMS-Plavix. In August of this year, a divided California Supreme Court ruled that Bristol-Myers Squibb is subject to state-court jurisdiction for legal claims from people who suffered bleeding or a stroke after taking its blood thinner Plavix. The conference discussions will be led by judges and practitioners from both the plaintiff and defense bars. It is intended to assist litigators in analyzing the significance of the decision for personal jurisdiction in future mass tort cases, and to facilitate an in-depth discussion of Judicial Council Coordinated Proceedings (“JCCP”) in California. Andre’s presentation will focus specifically on the details of the Supreme Court argument in the case.
Amy Zeman will attend and present at the 2016 Duke MDL Conference on October 27-28 in Arlington, Virginia. The invitation-only conference addresses emerging issues in large and mass-tort MDLs. Structured as an interactive discussion between practitioners, judges and professors, the conference is intended to lay the groundwork for the update and revision to the Duke Law Standards and Best Practices for Large and Mass-Tort MDLs. Topics to be addressed throughout the conference include: